Researchers discover a protein that triggers inflammatory responses in hemorrhage and sepsis

Investigators at The Feinstein Institute for Medical Research have discovered a protein in the human body that can trigger and mediate inflammation in patients suffering from hemorrhage and sepsis. The findings were published in the online version of Nature Medicine on October 6, 2013.

Thirty-seven million people are admitted to the emergency room with each year, and these injuries are a leading cause of death in the US. Two major reasons why traumatic injury is so deadly are loss of blood () and a clinical condition called . Sepsis occurs when molecules released into the bloodstream to fight an injury or infection trigger throughout the body. Inflammation is necessary for maintaining good health – without inflammation, wounds and infections would never be controlled or heal. However, persistent and constant inflammation often results in organ dysfunction or damage, leading to patient death – 28 to 50 percent of people who suffer from sepsis die from the condition.

For years, Feinstein Institute scientists have been researching ways to treat sepsis by halting persistent and constant inflammation. As a result of this effort, Ping Wang, MD, director for the Laboratory of Surgical Research and head of the Center for Translational Research at the Feinstein Institute, and his colleagues discovered that a protein called cold-inducible RNA-binding protein (CIRP) is increased and released into the bloodstream in response to hemorrhagic shock and sepsis. When CIRP triggers inflammation, it contributes to damage of organs in the body. Dr. Wang hypothesized that if CIRP activity is blocked, causing reduced inflammation, then patient survival will improve. To test this theory, he and his colleagues observed that treatment with an antibody against CIRP significantly increased survival rates during hemorrhage and sepsis in preclinical studies.

"In this study, we identified a small peptide that can be potentially developed as anti-CIRP compound," said Dr. Wang. "What this means for patients is that we may have discovered a molecule that could be used in the future to treat hemorrhage and sepsis and save many lives."

"There's a great need for new ways to diagnose and treat sepsis," said Sarah Dunsmore, PhD, of the National Institute of Health's National Institute of General Medical Sciences, which partially funded the research. "By targeting molecules such as CIRP, which are part of the body's normal response to stress, we may be able to tailor each patient's treatment based on how much damage has already been done and which organs are at risk of failure. Dr. Wang's work may also provide insight into how healthy cells survive extreme temperatures and other stressors, information that might be harnessed to treat a variety of disorders."

More information: Cold-inducible RNA-binding protein (CIRP) triggers inflammatory responses in hemorrhagic shock and sepsis, DOI: 10.1038/nm.3368

Related Stories

Researchers discover plant derivative

Nov 15, 2012

Researchers at The Feinstein Institute for Medical Research have discovered that tanshinones, which come from the plant Danshen and are highly valued in Chinese traditional medicine, protect against the life-threatening condition ...

Chinese cuisine could protect against sepsis

Oct 26, 2012

Researchers at The Feinstein Institute for Medical Research have discovered that a bean commonly used in Chinese cuisine protects against the life-threatening condition sepsis. These findings are published in the current ...

Surviving sepsis with LECT2

Dec 17, 2012

Failure to launch an adequate immune response may be at the root of septic shock, according to a study published in The Journal of Experimental Medicine on December 17th.

Recommended for you

Student seeks to improve pneumonia vaccines

8 hours ago

Almost a million Americans fall ill with pneumonia each year. Nearly half of these cases require hospitalization, and 5-7 percent are fatal. Current vaccines provide protection against some strains of the ...

Seabed solution for cold sores

10 hours ago

The blue blood of abalone, a seabed delicacy could be used to combat common cold sores and related herpes virus following breakthrough research at the University of Sydney.

Better living through mitochondrial derived vesicles

Aug 19, 2014

(Medical Xpress)—As principal transformers of bacteria, organelles, synapses, and cells, vesicles might be said to be the stuff of life. One need look no further than the rapid rise to prominence of The ...

Zebrafish help to unravel Alzheimer's disease

Aug 19, 2014

New fundamental knowledge about the regulation of stem cells in the nerve tissue of zebrafish embryos results in surprising insights into neurodegenerative disease processes in the human brain. A new study by scientists at ...

User comments